Cargando…
A Systematic Pan-Cancer Analysis of Genetic Heterogeneity Reveals Associations with Epigenetic Modifiers
Intratumor genetic heterogeneity (ITH) is the main obstacle to effective cancer treatment and a major mechanism of drug resistance. It results from the continuous evolution of different clones of a tumor over time. However, the molecular features underlying the emergence of genetically-distinct subc...
Autores principales: | de Matos, Mafalda Ramos, Posa, Ioana, Carvalho, Filipa Sofia, Morais, Vanessa Alexandra, Grosso, Ana Rita, de Almeida, Sérgio Fernandes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468518/ https://www.ncbi.nlm.nih.gov/pubmed/30897760 http://dx.doi.org/10.3390/cancers11030391 |
Ejemplares similares
-
A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma
por: Posa, Ioana, et al.
Publicado: (2016) -
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma
por: Grosso, Ana R, et al.
Publicado: (2015) -
Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers
por: Hopp, Lydia, et al.
Publicado: (2015) -
Epigenetic reprogramming by TET enzymes impacts co-transcriptional R-loops
por: Sabino, João C, et al.
Publicado: (2022) -
Histone methyltransferase SETD2 coordinates FACT recruitment with nucleosome dynamics during transcription
por: Carvalho, Sílvia, et al.
Publicado: (2013)